Variant report
Variant | nsv514697 |
---|---|
Chromosome Location | chr13:48783003-48784891 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:48784546..48786736-chr13:48788727..48791333,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551074839 | chr13:48783612-48783613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554282752 | chr13:48783619-48783620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187962580 | chr13:48783642-48783643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191139068 | chr13:48783648-48783649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs111595962 | chr13:48783669-48783670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs8000366 | chr13:48783695-48783696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138295283 | chr13:48783705-48783706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573936248 | chr13:48783708-48783709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs28688885 | chr13:48783718-48783719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs28679743 | chr13:48783719-48783720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs34311021 | chr13:48783782-48783783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182501909 | chr13:48783833-48783834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187729676 | chr13:48783840-48783841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546676366 | chr13:48783841-48783842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149614255 | chr13:48783879-48783880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376347698 | chr13:48783894-48783895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555951355 | chr13:48783906-48783907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192584548 | chr13:48783913-48783914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538207333 | chr13:48783922-48783923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184520078 | chr13:48783926-48783927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144394225 | chr13:48783981-48783982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555347380 | chr13:48784018-48784019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537433959 | chr13:48784059-48784060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561197657 | chr13:48784078-48784079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140984818 | chr13:48784109-48784110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201438435 | chr13:48784139-48784140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75102849 | chr13:48784190-48784191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544379729 | chr13:48784235-48784236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113444872 | chr13:48784238-48784239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562814548 | chr13:48784255-48784256 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533472035 | chr13:48784288-48784289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551447457 | chr13:48784306-48784307 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376336753 | chr13:48784372-48784373 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143438174 | chr13:48784422-48784423 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369484003 | chr13:48784430-48784431 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147146796 | chr13:48784477-48784478 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187519156 | chr13:48784488-48784489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192088366 | chr13:48784493-48784494 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531760372 | chr13:48784499-48784500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs550351379 | chr13:48784527-48784528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs78953303 | chr13:48784529-48784530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185009661 | chr13:48784553-48784554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553630170 | chr13:48784619-48784620 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565661012 | chr13:48784626-48784627 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536290667 | chr13:48784634-48784635 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs116853263 | chr13:48784689-48784690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs541627046 | chr13:48784706-48784707 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576428432 | chr13:48784714-48784715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189518833 | chr13:48784751-48784752 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs78312358 | chr13:48784769-48784770 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 21088497 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22048815 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:48783600-48784200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
2 | chr13:48783600-48785000 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr13:48783600-48785000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr13:48783600-48785000 | Enhancers | NHEK | skin |
5 | chr13:48783600-48785200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr13:48783600-48785200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr13:48783800-48784000 | Enhancers | NHLF | lung |
8 | chr13:48783800-48784600 | Enhancers | NHDF-Ad | bronchial |
9 | chr13:48783800-48784800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr13:48783800-48785000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
11 | chr13:48783800-48785200 | Enhancers | HMEC | breast |
12 | chr13:48784000-48784400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
13 | chr13:48784000-48784800 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
14 | chr13:48784000-48784800 | Enhancers | HSMM | muscle |
15 | chr13:48784000-48785000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr13:48784000-48785000 | Enhancers | Muscle Satellite Cultured Cells | -- |
17 | chr13:48784000-48785000 | Enhancers | Osteobl | bone |
18 | chr13:48784000-48785200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
19 | chr13:48784200-48784800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
20 | chr13:48784200-48785000 | Enhancers | Hela-S3 | cervix |
21 | chr13:48784200-48792600 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
22 | chr13:48784800-48788800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
23 | chr13:48784800-48791400 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |